BOVILIS Guardian

Bovine Rotavirus-Coronavirus Vaccine

Killed Virus, Clostridium Perfringens Types C & D-Escherichia Coli Bacterin-Toxoid

This product has been shown to be effective for the vaccination of healthy pregnant cattle to provide passive immunity against neonatal calf diarrhea due to bovine Group A Serotype G6 rotaviruses, enterotoxigenic E. coli pilus type K99, and bovine coronavirus, and enterotoxemia due to C. perfringens Types C & D in calves. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

DOSAGE: Shake well and administer a single 2.0 mL vaccination dose by subcutaneous route to pregnant cattle 3 months prior to calving and a single 2.0 mL booster dose 3 - 6 weeks following initial vaccination. For subsequent calvings, revaccinate with a single 2.0 mL dose 5 - 7 weeks prior to calving.

BOVILIS Guardian Caution

Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products. Do not vaccinate within 60 days before slaughter. Transient local reaction may occur at the injection site. Anaphylactoid reactions may occur following use. Antidote: Epinephrine. Contains gentamicin and thimerosal as preservatives. In case of human exposure, contact a physician.

FOR ANIMAL USE ONLY

Intervet Inc., d/b/a Merck Animal Health, Omaha, NE 68103 USA

VLN 165A/ PCN 4575.20 / 1-800-521-5767

For Patent info.: http://www.merck.com/product/patent/home.html

CPN: 1047566.0